Literature DB >> 19760540

Genetics of cystic fibrosis.

Sherstin T Lommatzsch1, Robert Aris.   

Abstract

Cystic fibrosis (CF) is a complicated disease involving many organ systems. Identification of the cystic fibrosis transmembrane regulator (CFTR) genetic code has not only enhanced our understanding of the mechanism of CF pathology but has also provided explanations for phenotypic variation. Additionally, genetic testing has refined our ability to identify patients with CF and CF-related illnesses. Genetic mutations may be grouped by class (I-VI) and are directly related to the quantity of CFTR protein produced. This has direct implications regarding the severity of disease and has suggested organ-specific sensitivity to the presence of normally functioning CFTR. Further, it has improved understanding of the mechanism behind seemingly organ-specific manifestations of CF, such as congenital bilateral absence of the vas deferens (CBVAD). Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760540     DOI: 10.1055/s-0029-1238911

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  12 in total

1.  Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator: A three-step biological approach to establishing a correlation between genotype and phenotype.

Authors:  Fleur Fresquet; Romain Clement; Caroline Norez; Adélaïde Sterlin; Patricia Melin; Frédéric Becq; Alain Kitzis; Vincent Thoreau; Frédéric Bilan
Journal:  J Mol Diagn       Date:  2011-06-25       Impact factor: 5.568

2.  Specific stabilization of CFTR by phosphatidylserine.

Authors:  Ellen Hildebrandt; Netaly Khazanov; John C Kappes; Qun Dai; Hanoch Senderowitz; Ina L Urbatsch
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-30       Impact factor: 3.747

3.  Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele.

Authors:  Angela Polizzi; Riccardina Tesse; Teresa Santostasi; Anna Diana; Antonio Manca; Vito Paolo Logrillo; Maria Domenica Cazzato; Maria Giuseppa Pantaleo; Lucio Armenio
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

4.  Accounting for a quantitative trait locus for plasma triglyceride levels: utilization of variants in multiple genes.

Authors:  Lisa J Martin; Ahmed H Kissebah; Michael Olivier
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

Review 5.  Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.

Authors:  Molla Imaduddin Ahmed; Saptarshi Mukherjee
Journal:  Cochrane Database Syst Rev       Date:  2018-07-27

Review 6.  Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment.

Authors:  Luiz Vicente Ribeiro Ferreira da Silva Filho; Flavia de Aguiar Ferreira; Francisco José Caldeira Reis; Murilo Carlos Amorim de Britto; Carlos Emilio Levy; Otavio Clark; José Dirceu Ribeiro
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

7.  Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.

Authors:  Maxine S Eikani; Melodee Nugent; Arash Poursina; Pippa Simpson; Hara Levy
Journal:  BMC Infect Dis       Date:  2018-07-06       Impact factor: 3.090

8.  MicroRNA Expression in Cystic Fibrosis Airway Epithelium.

Authors:  Catherine M Greene
Journal:  Biomolecules       Date:  2013-02-11

Review 9.  Cystic fibrosis related liver disease--another black box in hepatology.

Authors:  Katharina Staufer; Emina Halilbasic; Michael Trauner; Lili Kazemi-Shirazi
Journal:  Int J Mol Sci       Date:  2014-08-04       Impact factor: 5.923

Review 10.  The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.

Authors:  Christopher L R Barratt; Lars Björndahl; Christopher J De Jonge; Dolores J Lamb; Francisco Osorio Martini; Robert McLachlan; Robert D Oates; Sheryl van der Poel; Bianca St John; Mark Sigman; Rebecca Sokol; Herman Tournaye
Journal:  Hum Reprod Update       Date:  2017-11-01       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.